Building a Successful In-licensing
and Out-licensing Strategy

In-licensing and out-licensing has become more important for companies of all sizes and the atmosphere for attractive assets has become increasingly competitive. However, business development and licensing officials cannot go into “licensing mode” blindly.

In this whitepaper, Carlos Velez of Lacerta Bio discusses several topics to consider before investing in, planning and executing a business development initiative. He covers the challenges presented by organizational structure and the importance of goal setting, flexibility and story-telling in a business context.

read THE

By supplying my contact information, I authorize ShareVault to contact me about relevant content, products, and services. We're committed to your privacy, for more information, check out our  Privacy Policy .


Company team

Carlos N. Velez, Ph.D., MBA

Lacerta Bio  

Carlos has 20 years experience in pharmaceutical research, consulting, venture capital, entrepreneurship, and business development. Prior to co-founding Lacerta Bio, Carlos was the Director of Business Development and Licensing for Penwest Pharmaceuticals, a leading oral controlled release drug delivery company.  Learn More